LEADER 03600oam 2200673I 450 001 9910779248003321 005 20230124183826.0 010 $a1-280-87460-0 010 $a9786613715913 010 $a1-136-50028-6 010 $a1-136-50027-8 010 $a0-203-14332-9 024 7 $a10.4324/9780203143322 035 $a(CKB)2550000000104764 035 $a(EBL)981932 035 $a(OCoLC)798209483 035 $a(SSID)ssj0000741844 035 $a(PQKBManifestationID)12265371 035 $a(PQKBTitleCode)TC0000741844 035 $a(PQKBWorkID)10743488 035 $a(PQKB)11413363 035 $a(MiAaPQ)EBC981932 035 $a(OCoLC)798613037 035 $a(EXLCZ)992550000000104764 100 $a20180706d2012 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 10$aScience fiction /$fMark Bould 210 1$aNew York, N.Y. :$cRoutledge,$d2012. 215 $a1 online resource (257 p.) 225 1 $aRoutledge Film Guidebooks 300 $aDescription based upon print version of record. 311 $a0-415-45810-2 320 $aIncludes bibliographical references (pages [215]-228) and index. 327 $aCover; Title; Copyright; CONTENTS; Introduction; 1 The science in science fiction; The sound (and look) of science; The critical potential, pleasures and politics of 'bad' science; Unpicking science's self-image; The social subjectivity of (mad) scientists; The schizoid scientist, sexual terror and political complicity; Women in the lab: body parts; Women in the lab: scientists; Conclusion; 2 Sf, spectacle and self-reflexivity; Attractions; Spectacle, narrative and affect; Special effects and immersivity; The sublime; The grotesque; Camp 327 $aSelf-reflexivity: inanimating the animate, animating the inanimateSelf-reflexivity: surveillance, interpellation, reification, death; Conclusion; 3 Sf, colonialism and globalisation; Sf, cinema and the colonial imagination; Sf's colonial imaginary; Post-imperial melancholy in British sf; Race and anti-imperialism in US countercultural sf; Neo-liberalism and the sf of deindustrialisation; Sf figurations of neoliberal spaces; Representations of labour in contemporary sf; Conclusion; Notes; Bibliography; Index 330 $aScience Fiction explores the genre from 1895 to the present day, drawing on examples from over forty countries. It raises questions about the relationship between science fiction, science and technology, and examines the interrelationships between spectacle, narrative and self-reflexivity, paying particular attention to the role of special effects in creating meaning and affect. It explores science fiction's evocations of the sublime, the grotesque, and the camp, and charts the ways in which the genre reproduces and articulates discourses of colonialism, imperialism and neo-liberal 410 0$aRoutledge Film Guidebooks 606 $aScience fiction films -- History and criticism 606 $aScience fiction films$xHistory and criticism 606 $aMusic, Dance, Drama & Film$2HILCC 606 $aFilm$2HILCC 615 4$aScience fiction films -- History and criticism. 615 0$aScience fiction films$xHistory and criticism 615 7$aMusic, Dance, Drama & Film 615 7$aFilm 676 $a791.43/615 676 $a791.43615 700 $aBould$b Mark.$0858087 801 0$bAU-PeEL 801 1$bAU-PeEL 801 2$bAU-PeEL 906 $aBOOK 912 $a9910779248003321 996 $aScience fiction$93828208 997 $aUNINA LEADER 04899nam 22005773 450 001 9911019573803321 005 20240614080242.0 010 $a9781394234196 010 $a1394234198 010 $a9781394234189 010 $a139423418X 035 $a(MiAaPQ)EBC31466376 035 $a(Au-PeEL)EBL31466376 035 $a(CKB)32273948700041 035 $a(OCoLC)1439563870 035 $a(OCoLC-P)1439563870 035 $a(CaSebORM)9781394234165 035 $a(Perlego)4453229 035 $a(OCoLC)1439599199 035 $a(EXLCZ)9932273948700041 100 $a20240614d2024 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aArtificial Intelligence and Machine Learning in Drug Design and Development 205 $a1st ed. 210 1$aNewark :$cJohn Wiley & Sons, Incorporated,$d2024. 210 4$dİ2024. 215 $a1 online resource (670 pages) 225 1 $aFintech in a Sustainable Digital Society Series 311 08$a9781394234165 311 08$a1394234163 330 $aThe book is a comprehensive guide that explores the use of artificial intelligence and machine learning in drug discovery and development covering a range of topics, including the use of molecular modeling, docking, identifying targets, selecting compounds, and optimizing drugs. The intersection of Artificial Intelligence (AI) and Machine Learning (ML) within the field of drug design and development represents a pivotal moment in the history of healthcare and pharmaceuticals. The remarkable synergy between cutting-edge technology and the life sciences has ushered in a new era of possibilities, offering unprecedented opportunities, formidable challenges, and a tantalizing glimpse into the future of medicine. AI can be applied to all the key areas of the pharmaceutical industry, such as drug discovery and development, drug repurposing, and improving productivity within a short period. Contemporary methods have shown promising results in facilitating the discovery of drugs to target different diseases. Moreover, AI helps in predicting the efficacy and safety of molecules and gives researchers a much broader chemical pallet for the selection of the best molecules for drug testing and delivery. In this context, drug repurposing is another important topic where AI can have a substantial impact. With the vast amount of clinical and pharmaceutical data available to date, AI algorithms find suitable drugs that can be repurposed for alternative use in medicine. This book is a comprehensive exploration of this dynamic and rapidly evolving field. In an era where precision and efficiency are paramount in drug discovery, AI and ML have emerged as transformative tools, reshaping the way we identify, design, and develop pharmaceuticals. This book is a testament to the profound impact these technologies have had and will continue to have on the pharmaceutical industry, healthcare, and ultimately, patient well-being. The editors of this volume have assembled a distinguished group of experts, researchers, and thought leaders from both the AI, ML, and pharmaceutical domains. Their collective knowledge and insights illuminate the multifaceted landscape of AI and ML in drug design and development, offering a roadmap for navigating its complexities and harnessing its potential. In each section, readers will find a rich tapestry of knowledge, case studies, and expert opinions, providing a 360-degree view of AI and ML's role in drug design and development. Whether you are a researcher, scientist, industry professional, policymaker, or simply curious about the future of medicine, this book offers 19 state-of-the-art chapters providing valuable insights and a compass to navigate the exciting journey ahead. Audience The book is a valuable resource for a wide range of professionals in the pharmaceutical and allied industries including researchers, scientists, engineers, and laboratory workers in the field of drug discovery and development, who want to learn about the latest techniques in machine learning and AI, as well as information technology professionals who are interested in the application of machine learning and artificial intelligence in drug development. 410 0$aFintech in a Sustainable Digital Society Series 606 $aDrug development 615 0$aDrug development. 676 $a615.1/9 700 $aKhanna$b Abhirup$01840581 701 $aEl Barachi$b May$01740982 701 $aJain$b Sapna$01840582 701 $aKumar$b Manoj$0720895 701 $aNayyar$b Anand$01379041 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9911019573803321 996 $aArtificial Intelligence and Machine Learning in Drug Design and Development$94420159 997 $aUNINA